BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
41 – 50 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
(
- Contribution to journal › Letter
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
(
- Contribution to journal › Article
-
Mark
Proteogenomic characterization of patient-derived xenografts highlights the role of REST in neuroendocrine differentiation of castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
Clinical Application of Fusion Gene Detection Using Next-Generation Sequencing and the NanoString Technology
(
- Contribution to journal › Article
-
Mark
Using neutron crystallography to elucidate the basis of selective inhibition of carbonic anhydrase by saccharin and a derivative
(
- Contribution to journal › Article
-
Mark
Establishment of Melanoma Tumor Xenograft Using Single Cell Line Suspension and Co-injection of Patient-Derived T Cells in Immune-Deficient NSG Mice
(
- Contribution to journal › Article
-
Mark
Diagnostic spectrum and time intervals in Sweden's first diagnostic center for patients with nonspecific symptoms of cancer
(
- Contribution to journal › Article
-
Mark
Intravesical therapy - BCG and beyond
(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
(
- Contribution to journal › Article
-
Mark
EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
(
- Contribution to journal › Article